Ali Khan, MD, is departing his role as Aetna’s chief medical officer for Medicare, confirming the Ali Khan Aetna Medicare CMO departs news for a health plan business covering more than 4 million Medicare Advantage members.
Khan’s Tenure Behind This Ali Khan Aetna Medicare CMO Departs Announcement
Aetna’s Medicare Advantage has more than 4 million members. According to a Sept. 10 LinkedIn post, Dr. Khan joined Aetna Medicare in early 2024. Previously, he led value-based care at Oak Street Health, another CVS Health subsidiary, giving him direct prior experience within the same broader corporate family before stepping into this Medicare-focused clinical leadership role.
Why This Internal CVS Health Background Mattered for His Role
Having led value-based care at Oak Street Health before joining Aetna Medicare gave Khan established familiarity with CVS Health’s broader value-based care philosophy and operational approach, likely easing his transition into overseeing clinical strategy for Aetna’s substantial Medicare Advantage membership base.
Khan’s Own Reflection on This Aetna Medicare CMO Departure
“When I joined Aetna Medicare in early 2024, we were at an inflection point for the industry as a whole,” he said. “The work ahead was ambitious and meaningful: strengthening our clinical approach while reorienting around what I came to think of as last-mile clinical care — meeting every member where they are and closing the gaps that matter most.”
What “Last-Mile Clinical Care” Signals About His Approach
Khan’s framing of his tenure around “last-mile clinical care” suggests his leadership focus centered on closing the gap between clinical strategy and actual member-level care delivery, a distinction that speaks to a broader industry challenge facing Medicare Advantage plans: translating population-level value-based care goals into individualized member outcomes.
What Comes Next for Khan
Dr. Khan said he is still considering next steps. This lack of an announced destination leaves open whether Khan will remain within the broader CVS Health ecosystem, move to another Medicare Advantage insurer, or pursue an entirely different opportunity following his departure.
Why This Timing Coincides With Broader Payer Leadership Turnover
This announcement adds to a cluster of payer executive moves reported the same week, including UnitedHealthcare naming a new Washington state COO, Prime Therapeutics tapping a CFO from Walgreens, and a former CVS Pharmacy president winning a Democratic gubernatorial primary in Rhode Island, reflecting an active period of leadership transitions across the broader payer and healthcare industry.
What This Ali Khan Aetna Medicare CMO Departs Announcement Means Going Forward
With Khan’s departure leaving Aetna’s chief medical officer for Medicare position open, the insurer will need to identify new clinical leadership for a Medicare Advantage business covering more than 4 million members at a moment when Medicare Advantage plans broadly continue navigating star ratings pressure, cost containment, and membership shifts. Given Khan’s stated focus on “last-mile clinical care” during his tenure, his eventual successor may face questions about continuity in how Aetna approaches closing care gaps at the individual member level.
Why This Departure Arrives at a Sensitive Moment for Aetna’s Medicare Business
This leadership change comes as Aetna, alongside other major Medicare Advantage insurers, continues navigating star ratings disputes, benefit reductions, and cost pressures heading into the 2027 plan year. Given that CVS Health has publicly emphasized rebuilding trust and clinical credibility within its Medicare Advantage business following recent star ratings litigation, how quickly and with what profile Aetna fills this vacancy may be read as a signal of the company’s continued commitment to the clinical strategy Khan helped shape since 2024.
What to Watch Going Forward
As Aetna determines its next steps for Medicare clinical leadership, industry observers will likely watch who is named to succeed Khan and whether that appointment signals continuity with his stated clinical priorities or a shift in direction. Given the broader wave of payer executive transitions occurring across the industry this week, this Ali Khan Aetna Medicare CMO departs announcement adds to a pattern of significant leadership change reshaping how major insurers approach Medicare Advantage clinical strategy heading into the next enrollment cycle.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed
